Abbott Labs Path to Double-Digit Earnings Growth In 2025? This Analyst Is Optimistic [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
Organic sales growth for the underlying base business was 8.2%, led by double-digit growth in Medical Devices . Abbott's adjusted diluted earnings per share was $1.21, beating the analyst estimates of $1.20. Abbott projects full-year 2024 adjusted EPS of $4.64-$4.70 versus prior guidance of $4.61-$4.71 and consensus of $4.66. It forecasts fourth-quarter adjusted EPS of $1.31-$1.37 versus the consensus of $1.20. William Blair anticipates that Abbott will return to a more typical pattern of double-digit earnings growth in the fourth quarter, a trend that is expected to continue into 2025 as the company moves past the impacts of the “COVID-cloud” management mentioned earlier. Looking ahead to 2025, the analyst writes that Abbott has built a robust pipeline of products poised to drive a high-single-digit growth rate, an acceleration compared to pre-COVID levels. William Blair notes that the investment landscape remains attractive, particularly given Abbott's valuation compared to
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Sanford C. Bernstein from $133.00 to $138.00. They now have an "outperform" rating on the stock.MarketBeat
- Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at UBS Group AG from $143.00 to $146.00. They now have a "buy" rating on the stock.MarketBeat
- Company News for Oct 17, 2024 [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Jefferies Financial Group Inc. from $120.00 to $125.00. They now have a "hold" rating on the stock.MarketBeat
- Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Mizuho from $115.00 to $130.00. They now have a "neutral" rating on the stock.MarketBeat
ABT
Earnings
- 10/16/24 - Beat
ABT
Sec Filings
- 10/16/24 - Form 8-K
- 10/1/24 - Form 4
- 10/1/24 - Form 4
- ABT's page on the SEC website